Profiling Localized Immunomodulation and Drug Biodistribution within a Subcutaneous Vascularized Niche for Cell...

Area of Science:

• Immunology
• Transplantation Biology
• Biomedical Engineering

Background:

• Systemic immunosuppression is crucial for preventing transplant rejection but causes significant toxicity.
• Local immunomodulation presents a promising alternative, but comparative data on localized drug behavior is limited.

Purpose of the Study:

• To investigate the safety, efficacy, and pharmacokinetic profiles of locally delivered immunosuppressants using a novel implantable device.
• To compare the local and systemic immunomodulatory effects of five clinically relevant agents in allogeneic islet transplantation.

Main Methods:

• Utilized the Neovascularized Implantable Cell Homing and Encapsulation (NICHE) device for localized drug delivery in a subcutaneous allogeneic islet transplantation model.
• Systematically profiled safety, local/systemic immunomodulation, pharmacokinetics, and biodistribution of CTLA4-Ig, anti-lymphocyte serum, anti-CD40L, anti-CD2, and anti-IL6.

Main Results:

• Local delivery confined immunosuppressants to the graft site, achieving up to 100-fold lower systemic concentrations without impairing islet viability or function.
• Each agent induced distinct immune signatures, including lymphocyte depletion and altered T-cell activation.

Conclusions:

• Localized immunosuppression via the NICHE device is safe and effective, significantly reducing systemic exposure and toxicity.
• This comparative framework guides mechanism-informed combinations for improved allogeneic cell transplantation and cell therapy.